SCHEMBL6467439

SCHEMBL6467439

Cn1c(C(N)=O)cc2cc(OCc3cccc(NC(=O)[C@@H](N)CCC(N)=O)c3)ccc21

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AS3MT Q9HBK9 1/20 0.52
SRD5A2 P31213 1/20 0.50
LTA4H P09960 9/20 0.46
KDM1A O60341 3/20 0.43
RCOR1 Q9UKL0 3/20 0.43
CYSLTR1 Q9Y271 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
SIRT3 Q9NTG7 1/20 0.40
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
GALR3 O60755 1/20 0.39
GAA P10253 1/20 0.39
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6087646 0.94 LTA4H (0.55) AS3MTSRD5A2LTA4HKDM1ARCOR1
SCHEMBL6087655 0.94 LTA4H (0.55) AS3MTSRD5A2LTA4HKDM1ARCOR1
SCHEMBL6087307 0.82 SRD5A2 (0.48) AS3MTSRD5A2LTA4HKDM1ARCOR1
SCHEMBL6087534 0.77 SRD5A2 (0.64) AS3MTSRD5A2MEN1NPC1RAB9A
SCHEMBL6087478 0.77 SRD5A2 (0.81) SRD5A2MEN1NPC1RAB9AKMT2A
SCHEMBL6087315 0.74 SRD5A2 (0.48) SRD5A2LTA4HMEN1NPC1RAB9A
SCHEMBL6087316 0.74 SRD5A2 (0.48) SRD5A2LTA4HMEN1NPC1RAB9A
SCHEMBL5640259 0.74 MAOB (0.48) AS3MTLTA4HMAOB
SCHEMBL6087410 0.73 SRD5A2 (0.58) SRD5A2MEN1NPC1RAB9AKMT2A
SCHEMBL6087661 0.73 CFD (0.60) AS3MTSRD5A2LTA4HSIRT2SIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515716-A2 INDOLE DERIVATIVES HAVING ANTI-ANGIOGENETIC ACTIVITY Astrazeneca AB (SE) 2005-03-23 EP disclosed
WO-2003082271-A2 INDOLE DERIVATIVES HAVING ANTI-ANGIOGENETIC ACTIVITY ASTRAZENECA AB (SE) 2003-10-09 WO disclosed